Results 161 to 170 of about 4,586,853 (323)
KMT2A degradation is observed in decitabine‐responsive acute lymphoblastic leukemia cells
We demonstrate that decitabine (DEC) not only degrades the DNA methyltransferase DNMT1 but also the leukemic driver lysine methyltransferase KMT2A likely due to structural similarity of the DNA‐binding CXXC domains. DEC influences KMT2A downstream processes and synergizes with menin inhibitor revumenib (REV) to decrease leukemic cell proliferation, and
Luisa Brock+10 more
wiley +1 more source
Easing the Transfer of Students from College to University Programs: How Can Learning Outcomes Help?
Irene Carter+2 more
openalex +2 more sources
EFFECTS OF INSULIN ON PLACENTAL, FETAL AND MATERNAL OUTCOMES IN GESTATIONAL DIABETES MELLITUS [PDF]
Rabia Arshad+2 more
openalex +1 more source
CD226+CD8+ T cells express elevated levels of RUNX2, exhibit higher proliferation capacity, cytokines and cytolytic molecules expression, and migratory capacity. In contrast, CD226−CD8+ T cells display an exhausted phenotype associated with the increased expression of co‐inhibitory receptors and impaired effector functions.
Maryam Rezaeifar+4 more
wiley +1 more source
Comparison of Online Peer-Assisted Learning and Faculty-Led Teaching for Short Answer Questions. [PDF]
Samra GS+5 more
europepmc +1 more source
Frequency and outcome of treatment in polycystic ovaries related infertility [PDF]
Farzana Rizwan
openalex +1 more source
Triacsin C inhibition of the acyl‐CoA synthetase long chain (ACSL) family decreases multiple myeloma cell survival, proliferation, mitochondrial respiration, and membrane potential. Made with Biorender.com. Multiple myeloma (MM) is an incurable cancer of plasma cells with a 5‐year survival rate of 59%.
Connor S. Murphy+12 more
wiley +1 more source
Evolution of the Florida Pediatric Bone Marrow Transplant and Cell Therapy Consortium (FPBCC): A Statewide Initiative Toward Improving Transplant Outcomes. [PDF]
Alperstein W+15 more
europepmc +1 more source